Co-Diagnostics Statistics

Total Valuation

Co-Diagnostics has a market cap or net worth of $22.80 million. The enterprise value is $12.83 million.

Market Cap	22.80M
Enterprise Value	12.83M

Important Dates

The last earnings date was Thursday, November 13, 2025, after market close.

Earnings Date	Nov 13, 2025
Ex-Dividend Date	n/a

Share Statistics

Co-Diagnostics has 60.89 million shares outstanding. The number of shares has increased by 11.72% in one year.

Current Share Class	60.89M
Shares Outstanding	60.89M
Shares Change (YoY)	+11.72%
Shares Change (QoQ)	+14.45%
Owned by Insiders (%)	5.08%
Owned by Institutions (%)	12.38%
Float	54.06M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	24.70
Forward PS	19.44
PB Ratio	0.45
P/TBV Ratio	1.66
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	25.27
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.81, with a Debt / Equity ratio of 0.04.

Current Ratio	3.81
Quick Ratio	3.36
Debt / Equity	0.04
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -62.12% and return on invested capital (ROIC) is -41.33%.

Return on Equity (ROE)	-62.12%
Return on Assets (ROA)	-37.92%
Return on Invested Capital (ROIC)	-41.33%
Return on Capital Employed (ROCE)	-86.56%
Revenue Per Employee	$3,848
Profits Per Employee	-$243,799
Employee Count	132
Asset Turnover	0.01
Inventory Turnover	0.28

Taxes

Income Tax	-1.15M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -57.25% in the last 52 weeks. The beta is 1.16, so Co-Diagnostics's price volatility has been higher than the market average.

Beta (5Y)	1.16
52-Week Price Change	-57.25%
50-Day Moving Average	0.39
200-Day Moving Average	0.35
Relative Strength Index (RSI)	49.90
Average Volume (20 Days)	1,784,935

Short Selling Information

The latest short interest is 1.71 million, so 2.81% of the outstanding shares have been sold short.

Short Interest	1.71M
Short Previous Month	2.41M
Short % of Shares Out	2.81%
Short % of Float	3.16%
Short Ratio (days to cover)	0.23

Income Statement

In the last 12 months, Co-Diagnostics had revenue of $507,892 and -$32.18 million in losses. Loss per share was -$0.97.

Revenue	507,892
Gross Profit	172,843
Operating Income	-35.53M
Pretax Income	-33.33M
Net Income	-32.18M
EBITDA	-34.33M
EBIT	-35.53M
Loss Per Share	-$0.97

Full Income Statement

Balance Sheet

The company has $11.44 million in cash and $1.47 million in debt, giving a net cash position of $9.97 million or $0.16 per share.

Cash & Cash Equivalents	11.44M
Total Debt	1.47M
Net Cash	9.97M
Net Cash Per Share	$0.16
Equity (Book Value)	39.83M
Book Value Per Share	0.83
Working Capital	10.36M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$31.17 million and capital expenditures -$641,065, giving a free cash flow of -$31.81 million.

Operating Cash Flow	-31.17M
Capital Expenditures	-641,065
Free Cash Flow	-31.81M
FCF Per Share	-$0.52

Full Cash Flow Statement

Margins

Gross Margin	34.03%
Operating Margin	-6,995.70%
Pretax Margin	-6,562.78%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Co-Diagnostics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-11.72%
Shareholder Yield	-11.72%
Earnings Yield	-141.12%
FCF Yield	-139.49%

Analyst Forecast

The average price target for Co-Diagnostics is $2.25, which is 500.80% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$2.25
Price Target Difference	500.80%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Co-Diagnostics has an Altman Z-Score of -1.69 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.69
Piotroski F-Score	1